Patients with COVID-19-induced ARDS have higher serum levels of endothelial damage markers such as angiopoietin-2, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, P-selectin, and E-selectin than patients with other types of ARDS [127]. The gene discussed is SELP; the disease is COVID-19.